Acutaas Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
ACUTAAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Acutaas Chemicals Limited reported strong FY2025-26 results with consolidated revenue from operations of ₹13,394 lakhs, up 33% from ₹10,067 lakhs in the previous year. Net profit after tax surged to ₹3,564 lakhs from ₹1,604 lakhs, representing over 122% growth. The Board recommended a final dividend of ₹2.50 per share (50% on face value ₹5), subject to shareholder approval. The company has identified Indichem Inc. as a material subsidiary following an investment of approximately ₹190.52 crores. Statutory auditors Maheshwari & Co. issued an unmodified (clean) audit opinion on both standalone and consolidated financial results. Q4 FY26 standalone revenue was ₹4,218 lakhs, up 39% year-on-year.
The company delivered exceptional double-digit growth in both revenue and profitability, which is positive for shareholders. The clean audit with no qualifications or going concern notes indicates financial health. The dividend announcement provides income certainty for investors.